TenOever’s interest in interferons’ roles in infection goes back to his days at McGill University. During an undergraduate microbiology class, tenOever attended a lecture about viruses, which ignited ...

Benjamin tenOever, Ph.D., Assistant Professor in the Department of Microbiology at Mount Sinai School of Medicine, has been selected by the United States government for a Presidential Early Career ...

Differences may end worry that new drug classes based on invertebrate mechanisms could disrupt human immune defenses. Mammals use a form of RNAi to fine-tune the expression of hundreds of genes that ...

Flu viruses can tell time. Sort of. And the viral clock-watching could provide a new way to fight the flu. A study in Cell Reports describes how researchers tapped into the flu's internal clock as ...

The strategy will enable healthy molecules in human lung cells to latch on to these viruses and cut the bugs up before they have a chance to infect the human host. A new strategy that dismantles a ...

Benjamin tenOever, Ph.D., Assistant Professor of Microbiology, Mount Sinai School of Medicine, New York, has been chosen by the American Society for Microbiology (ASM) to receive a 2010 ICAAC Young ...

A majority of people in the U.S have had COVID-19 at least once — likely more than 70% of the country, White House COVID-19 Response Coordinator Ashish Jha said on Thursday, citing data from the ...

"We do not have any reason to assume that the immune response would be significantly different" from what's seen with other coronaviruses, said Nicolas Vabret, an assistant professor of medicine at ...

Researchers have found a potential weakness in the armor of the influenza virus, which is causing a tough flu season across the United States this year. They’ve found a flaw in a timekeeping mechanism ...

One of the more notorious symptoms of COVID-19 is the loss of taste and smell. There are varying estimates on just how many tongues and noses went out of business, but one study shows that as many as ...

Hebrew University Professor Yaakov Nahmias. Could a simple drug, that has been on the market for decades, be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)’s ...